Skip to content

Allergan’s ex-CEO Brent Saunders launching blank-check company

September 11, 2020

Vesper Healthcare Acquisition has filed to raise $400M in an IPO, with listing on the Nasdaq under the symbol “VSRU.” Goldman Sachs and JPMorgan are underwriting.

Ex-Allergan CEO Brent Saunders is leading the effort, and he’s brought along Manisha Narasimhan, who was SVP of strategic initiatives, portfolio innovation, and investor relations at Allergan.

The focus of Saunders’ SPAC will be medical aesthetics, eyecare, longevity and wellness categories, though it may pursue targets in any industry.

Saunders became CEO of Allergan in 2014 after his generics firm Actavis purchased the company. He departed after the sale to AbbVie (NYSE:ABBV).

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: